Akebia Therapeutics, Inc.
DE ˙ DB ˙ US00972D1054
0,83 € ↓ -0,02 (-2,69%)
2026-06-03
AKTIENPREIS
SecurityDE:AX9 / Akebia Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership581,327 shares
Latest Disclosed Value $ 808,044
Morgan Stanley reports 52.69% decrease in ownership of AX9 / Akebia Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 581,327 shares of Akebia Therapeutics, Inc. (DE:AX9) valued at $663,294 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 1,228,816 shares of Akebia Therapeutics, Inc.. This represents a change in shares of -52.69% during the quarter. The current value of the position is $482,966 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AKEBIA THREAPEUTICS COM 00972D105 581,327 -647,489 -52.69 808 -59.15 0.0000
2026-05-27 2025-12-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 1,228,816 -3,086,385 -71.52 1,978 -83.21 0.0001
2026-02-13 2025-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 1,228,816 -3,086,385 1,978 0.0001
2026-05-27 2025-09-30 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 4,315,201 -1,024,453 -19.19 11,780 -39.39 0.0007
2025-11-14 2025-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 4,315,201 -1,024,453 11,780 0.0007
2025-08-15 2025-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 5,339,654 2,658,456 99.15 19,436 277.62 0.0013
2025-05-15 2025-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 2,681,198 891,147 49.78 5,148 51.34 0.0004
2025-05-15 2024-12-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 1,790,051 701,159 64.39 3,401 136.67 0.0002
2025-02-14 2024-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 1,790,051 701,159 3,401 0.0002
2025-05-14 2024-09-30 13F/A-2 AKEBIA THERAPEUTICS COM 00972D105 1,088,892 325,560 42.65 1,437 84.70 0.0001
2025-02-14 2024-09-30 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 1,088,892 325,560 1,437 0.0001
2024-11-14 2024-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 1,088,892 325,560 1,437 0.0000
2025-05-14 2024-06-30 13F/A-2 AKEBIA THERAPEUTICS COM 00972D105 763,332 -25,043 -3.18 779 -46.05 0.0001
2024-10-17 2024-06-30 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 763,332 -25,043 779 0.0001
2024-08-14 2024-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 763,332 -25,043 779 0.0001
2024-10-17 2024-03-31 13F/A-2 AKEBIA THERAPEUTICS COM 00972D105 788,375 114,596 17.01 1,443 72.69 0.0001
2024-08-16 2024-03-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 788,375 114,596 1,443 0.0001
2024-05-15 2024-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 788,375 114,596 1,443 0.0001
2024-08-16 2023-12-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 673,779 261,950 63.61 835 78.04 0.0001
2024-02-13 2023-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 673,779 261,950 835 0.0001
2023-11-15 2023-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 411,829 37,205 9.93 469 37.13 0.0000
2023-08-14 2023-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 374,624 -269,493 -41.84 343 -5.00 0.0000
2023-05-15 2023-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 644,117 302,988 88.82 361 83.67 0.0000
2023-02-14 2022-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 341,129 -6,389 -1.84 197 78.18 0.0000
2022-11-14 2022-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 347,518 -309,021 -47.07 110 -52.59 0.0000
2022-10-27 2022-06-30 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 656,539 -339,175 -34.06 232 -67.51 0.0000
2022-08-15 2022-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 656,539 -339,175 232 0.0000
2022-10-27 2022-03-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 995,714 -200,500 -16.76 714 -73.58 0.0001
2022-05-13 2022-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 995,714 -200,500 714 0.0001
2022-02-14 2021-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 1,196,214 -277,291 -18.82 2,703 -36.31 0.0003
2021-11-15 2021-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 1,473,505 -1,186,868 -44.61 4,244 -57.91 0.0006
2021-08-23 2021-06-30 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 2,660,373 -680,337 -20.37 10,083 -10.83 0.0013
2021-08-16 2021-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 2,660,373 -680,337 10,083 0.0013
2021-05-17 2021-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 3,340,710 3,080,193 1,182.34 11,308 1,451.17 0.0017
2021-02-16 2020-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 260,517 -940,739 -78.31 729 -75.81 0.0001
2020-11-13 2020-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 1,201,256 986,634 459.71 3,014 3.43 0.0006
2020-08-14 2020-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 214,622 37,240 20.99 2,914 116.49 0.0006
2020-05-26 2020-03-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 177,382 -808,653 -82.01 1,346 -78.40 0.0004
2020-05-15 2020-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 177,382 -808,653 1,346 103.4009
2020-02-14 2019-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 986,035 -33,635 -3.30 6,231 55.85 0.0014
2019-11-14 2019-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 1,019,670 -188,721 -15.62 3,998 -31.65 0.0011
2019-08-14 2019-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 1,208,391 -119,137 -8.97 5,849 -46.21 0.0016
2019-05-15 2019-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 1,327,528 293,620 28.40 10,873 90.19 0.0031
2019-02-14 2018-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 1,033,908 -853,528 -45.22 5,717 -65.70 0.0017
2019-04-23 2018-09-30 13F/A-2 AKEBIA THERAPEUTICS COM 00972D105 1,887,436 496,069 35.65 16,666 20.01 0.0042
2018-11-20 2018-09-30 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 1,887,436 0 16,666 0.0042
2018-11-14 2018-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 1,887,436 496,069 16,666
2019-04-23 2018-06-30 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 1,391,367 217,504 18.53 13,887 24.15 0.0038
2018-08-14 2018-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 1,391,367 217,504 13,887
2019-04-23 2018-03-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 1,173,863 406,975 53.07 11,186 -1.90 0.0031
2018-05-14 2018-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 1,173,863 406,975 11,186
2019-04-23 2017-12-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 766,888 54,516 7.65 11,403 -18.62 0.0031
2018-02-14 2017-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 766,888 54,516 11,403
2017-11-14 2017-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 712,372 9,667 1.38 14,012 38.77 0.0042
2017-08-11 2017-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 702,705 -167,737 -19.27 10,097 26.09 0.0031
2017-05-22 2017-03-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 870,442 55,369 6.79 8,008 -5.61 0.0025
2017-05-12 2017-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 870,442 8,008
2017-02-22 2016-12-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 815,073 477,567 141.50 8,484 177.80 0.0028
2017-02-13 2016-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 815,073 8,484
2016-11-10 2016-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 337,506 116,001 52.37 3,054 84.42 0.0010
2016-08-12 2016-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 221,505 -12,243 -5.24 1,656 -21.37 0.0006
2016-05-12 2016-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 233,748 134,602 135.76 2,106 64.53 0.0008
2016-02-09 2015-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 99,146 -13,763 -12.19 1,280 17.32 0.0005
2016-02-08 2015-09-30 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 112,909 64,722 134.31 1,091 119.96 0.0004
2015-11-09 2015-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 112,909 1,091
2015-08-12 2015-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 48,187 -7,638 -13.68 496 -20.00 0.0002
2015-05-14 2015-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 55,825 -67,710 -54.81 620 -56.88 0.0002
2015-02-13 2014-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 123,535 -179,377 -59.22 1,438 -78.55 0.0005
2014-12-16 2014-09-30 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 302,912 -93,937 -23.67 6,704 -39.21 0.0026
2014-11-14 2014-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 302,912 6,704
2014-08-12 2014-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 396,849 396,849 11,028 0.0189
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.